Lyka Labs P/E Ratio
Lyka Labs (LYKALABS) P/E ratio is not applicable — EPS (TTM) ₹-2.81, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹-2.81
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -2.10 | -8 | Loss |
| Jun 2026 | 0.57 | 2 | Profit |
| Sept 2025 | -0.94 | -3 | Loss |
| Mar 2025 | 0.49 | 2 | Profit |
| Jun 2025 | 0.25 | 1 | Profit |
| Sept 2024 | 0.58 | 2 | Profit |
| Mar 2024 | -3.83 | -2 | Loss |
| Jun 2024 | 0.40 | 1 | Profit |
Healthcare Peers with Valid P/E Ratios — LYKALABS Comparison
Healthcare sector average P/E 54.89, median 30.62 — LYKALABS excluded (negative EPS).
Sector Average PE
54.89
Sector Median PE
30.62
Lowest PE
2.86
Profitable Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 2.98 | ₹52 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see LYKALABS share price screener.
- Compare with Lyka Labs value estimation to assess whether the stock is under or overvalued.
- View LYKALABS 52-week high low for the annual high/low range and current price position.